Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

Roquefort Thera (ROQ) Share Price

Price 1.675p on 28-03-2025 at 17:30:01
Change 0.00p 0%
Buy 1.70p
Sell 1.65p
Buy / Sell ROQ Shares
Last Trade: Sell 57,333.00 at 1.665p
Day's Volume: 1,103,831
Last Close: 1.675p
Open: 1.675p
ISIN: GB00BMDQ2T15
Day's Range 1.675p - 1.675p
52wk Range: 1.50p - 7.00p
Market Capitalisation: £3m
VWAP: 1.66064p
Shares in Issue: 155m

Roquefort Thera (ROQ) Latest Trades

Buy/Sell Volume Trade Prc Trade Type Trade Time
Sell* 57,333 1.665p Ordinary
16:13:28 - 28-Mar-25
Sell* 27,634 1.65p Ordinary
15:41:19 - 28-Mar-25
Sell* 27,634 1.65p Ordinary
11:49:49 - 28-Mar-25
Sell* 5,000 1.669p Ordinary
11:16:01 - 28-Mar-25
Sell* 14,547 1.669p Ordinary
10:53:49 - 28-Mar-25
Sell* 12,482 1.65p Ordinary
10:29:49 - 28-Mar-25
Sell* 100,000 1.65p Ordinary
10:28:59 - 28-Mar-25
Sell* 105,497 1.65p Ordinary
10:27:50 - 28-Mar-25
Buy* 58,910 1.679p Ordinary
10:24:31 - 28-Mar-25
Buy* 118,173 1.679p Ordinary
10:23:51 - 28-Mar-25
See more Roquefort Thera trades

Roquefort Thera (ROQ) Share Price History

Time period:
to
Date Open High Low Close Volume
28th Mar 2025 (Fri) 1.675 1.675 1.675 1.675 1,103,831
27th Mar 2025 (Thu) 1.65 1.825 1.65 1.675 1,723,288
26th Mar 2025 (Wed) 1.90 1.87 1.65 1.65 2,966,834
25th Mar 2025 (Tue) 1.90 1.90 1.90 1.90 519,758
24th Mar 2025 (Mon) 1.90 2.10 1.85 1.90 3,245,776
21st Mar 2025 (Fri) 2.15 2.15 1.90 1.90 722,744
20th Mar 2025 (Thu) 2.20 2.20 1.90 2.15 3,202,533
19th Mar 2025 (Wed) 2.20 2.25 1.95 2.20 8,249,967
18th Mar 2025 (Tue) 2.20 2.66 2.10 2.20 7,790,216
17th Mar 2025 (Mon) 1.90 2.45 2.10 2.20 13,206,984
14th Mar 2025 (Fri) 1.60 1.90 1.60 1.90 11,272,962
13th Mar 2025 (Thu) 1.825 1.85 1.55 1.60 15,413,373
12th Mar 2025 (Wed) 1.90 1.90 1.83 1.83 10,889,408
11th Mar 2025 (Tue) 2.30 2.34 1.90 1.90 10,528,950
10th Mar 2025 (Mon) 1.90 2.40 2.40 2.40 28,658,486
7th Mar 2025 (Fri) 1.55 1.55 1.55 1.55 305,131
6th Mar 2025 (Thu) 1.55 1.55 1.55 1.55 11,915
5th Mar 2025 (Wed) 1.55 1.55 1.55 1.55 20,000
4th Mar 2025 (Tue) 1.70 1.70 1.55 1.55 542,279
3rd Mar 2025 (Mon) 1.80 1.80 1.50 1.60 1,690,297
See more Roquefort Thera price history

Roquefort Thera (ROQ) Regulatory News

Date Source Headline
14th Mar 2025 7:00 am RNS Private Placing and Conversion of CLNs
10th Mar 2025 7:30 am RNS Board Changes
10th Mar 2025 7:00 am RNS Proposed Sale of Oncogeni Ltd
4th Mar 2025 7:00 am RNS Update on Sale of Lyramid
4th Feb 2025 10:58 am RNS Director/PDMR Shareholding
3rd Feb 2025 7:00 am RNS Share Purchase Agreement Signed - Sale of Lyramid
2nd Jan 2025 7:00 am RNS Proposed Sale of Midkine Portfolio
4th Dec 2024 4:00 pm RNS Director Share Distribution
7th Nov 2024 7:00 am RNS Conversion of Convertible Loan Notes
27th Sep 2024 7:00 am RNS Interim Results to 30 June 2024
See more Roquefort Thera regulatory news

Roquefort Thera (ROQ) Share News

Roquefort Therapeutics CEO resigns, agrees terms for Oncogeni disposal

10th Mar 2025 11:38

(Alliance News) - Roquefort Therapeutics PLC on Monday said it has agreed the terms for the proposed sale of its wholly-owned subsidiary Oncogeni Ltd to UAE-based conglomerate Nations Trust Holding LLC, for up to USD12 million. Read More

SMALL-CAP WINNERS & LOSERS: Roquefort jumps on Oncogeni deal

10th Mar 2025 10:04

(Alliance News) - The following stocks are the leading risers and fallers among London Main Market small-caps on Monday. Read More

Roquefort Therapeutics proposes USD10 million subsidiary sale

2nd Jan 2025 14:08

(Alliance News) - Roquefort Therapeutics PLC on Thursday said it has proposed the sale of subsidiary Lyramid Pty Ltd to Pleiades Pharma Ltd for a minimum of USD10 million. Read More

EARNINGS: Kendrick Resources loss narrows; Emmerson CFO to depart

27th Sep 2024 13:56

(Alliance News) - The following is a round-up of earnings for London-listed companies, issued on Friday and not separately reported by Alliance News: Read More

Roquefort Therapeutics says MK cell therapy patent approved in Japan

23rd Sep 2024 17:51

(Alliance News) - Roquefort Therapeutics PLC on Monday announced its patent for mesodermal killer, or MK, cell therapy has been approved by the Japan Patent Office. Read More

See more Roquefort Thera news
FTSE 100 Latest
Value8,658.85
Change-7.27

Login to your account

Forgot Password?

Not Registered